Adaptive Biotechnologies (ADPT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec16

JP Morgan Reiterates Buy Rating on Adaptive Biotechnologies with $20 Price Target

08:37

Dec15

Adaptive Biotechnologies Corporation Signs Non-Exclusive Agreements with Pfizer

13:00

Dec13

Robert Herdman Disposes of Adaptive Biotechnologies Corporation Common Stock

00:11

Dec9

Adaptive Biotechnologies Executives to Participate in Jefferies Fireside Chat

22:07

Dec6

Adaptive Biotechnologies Unveils New Data for clonoSEQ® Test in MRD Monitoring

13:30

Dec5

Adaptive Biotechnologies CSO Sells Shares

23:31

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 93.97 M, Net Income 9.546 M, EPS 0.0599

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 58.88 M, Net Income -25.61 M, EPS -0.1684

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 52.44 M, Net Income -29.85 M, EPS -0.2

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change